跳至主要内容
临床试验/CTRI/2013/01/003312
CTRI/2013/01/003312已完成未知

To study serum homocysteine levels and total Antioxidant Status in vitiligo patients

Employees State Insurance Corporation Post Graduate Institute of Medical Sciences Research0 个研究点目标入组 150 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Patients with vitiligo attending dermatology outpatient clinic
  • 2. Age group 18-45 years (at the time of entry into study)
  • 3. Constant dietary habits for the past 1 year

排除标准

  • 1. Cigarette smoking
  • 2. Alcohol intake during past 3 months
  • 3. Intake of folic acid, vitamin B6 and B12 during past 2 months
  • 4. Intake of antioxidant supplements during past 3 months
  • 5. Any systemic disease associated with altered serum Hcy levels. This will include known cases of cardiovascular disease, renal failure, diabetes mellitus, hypertension, hypothyroidism, hyperthyroidism & chronic liver disease and patients with any relevant findings on general and systemic examination.
  • 6. Dermatological diseases known to affect serum Hcy levels, including psoriasis, Behcetâ??s disease, SLE.
  • 7. Intake of any drugs known to affect Hcy levels, including methotrexate, INH, isotretinoin, cyclosporine, penicillamine, phenytoin, carbamazepine, OCPs, hydralazine, L-dopa, procarbazine, acetylcysteine, cholestyramine and cycloserine.
  • 8. Pregnant females and females in 1-week postpartum period
  • 9. Patients with any haematological or biochemical abnormality observed during routine laboratory investigations

研究者

发起方
Employees State Insurance Corporation Post Graduate Institute of Medical Sciences Research

相似试验